Concepedia

Joseph M. Parker

JM

22

Publications

1.3K

Citations

18

H-Index

1993

Active since

Affiliations

Walter Reed Army Institute of Research(Current)

Uniformed Services University of the Health Sciences

Oslo University Hospital

Indiana Hemophilia and Thrombosis Center

AstraZeneca (United States)

Joseph M. Parker is an author at Walter Reed Army Institute of Research specializing in medicine, asthma, and allergy.

Top concepts

Publications per year

1993–2023

22

Publications

22

A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma

Richard M. Nowak, Joseph M. Parker, Robert A. Silverman et al. · The American Journal of Emergency Medicine · 2014 · 204 citations

, , +7

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

Joseph M. Parker, Chad K. Oh, Craig LaForce et al. · BMC Pulmonary Medicine · 2011 · 142 citations · Full text

Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation

Daina B. Esposito, Stephan Lanes, Macarius Donneyong et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 141 citations

A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis

Joseph M. Parker, Ian Glaspole, Lisa Lancaster et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 127 citations

Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis

Nasreen Khalil, H. Manganas, Christopher J. Ryerson et al. · European Respiratory Journal · 2018 · 106 citations · Full text

Rows per page

1–5 of 22